SCHEMBL3166342

SCHEMBL3166342

CC(=O)NCCNc1cc(NC(=O)CN2CCN(c3ccc([N+](=O)[O-])cc3)CC2)nc(-c2ccccc2)n1

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.57
▸ SMN1; SMN2 Q16637 4/20 0.57
▸ MAPT P10636 3/20 0.57
▸ LMNA P02545 2/20 0.57
▸ POLB P06746 1/20 0.49
▸ GAA P10253 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ GFER P55789 1/20 0.45
▸ MCL1 Q07820 1/20 0.45
▸ EGFR P00533 2/20 0.44
▸ ABCG2 Q9UNQ0 1/20 0.44
▸ HTR1A P08908 1/20 0.44
▸ MAPK1 P28482 1/20 0.43
▸ KMT2A Q03164 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ USP2 O75604 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3162425 0.91 EGFR (0.53) ALDH1A1SMN1; SMN2MAPTLMNAGAA
SCHEMBL3166249 0.89 GAA (0.54) ALDH1A1SMN1; SMN2MAPTPOLBGAA
SCHEMBL3170421 0.89 SMN1; SMN2 (0.55) ALDH1A1SMN1; SMN2GAAKDM4EEGFR
SCHEMBL3162806 0.88 JAK3 (0.51) ALDH1A1SMN1; SMN2MAPTLMNAGAA
SCHEMBL3161698 0.88 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2LMNAGAAEGFR
SCHEMBL3175543 0.88 EGFR (0.50) ALDH1A1SMN1; SMN2MAPTLMNAGAA
SCHEMBL3165286 0.87 USP2 (0.57) ALDH1A1SMN1; SMN2MAPTLMNAPOLB
SCHEMBL3258722 0.86 EGFR (0.46) ALDH1A1SMN1; SMN2MAPTLMNAGAA
SCHEMBL3164831 0.84 MAPT (0.50) ALDH1A1SMN1; SMN2MAPTLMNAGAA
SCHEMBL3160939 0.84 ALDH1A1 (0.52) ALDH1A1SMN1; SMN2LMNAPOLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback